The Council will meet on January 10 (Monday). The agenda is: Preparation of a position on the evaluation of the drug Jardiance (empagliflozinum) in the indication: chronic heart failure in adult patients with reduced left ventricular ejection fraction (LVEF ≤ 40%) and persistent disease symptoms...
The decision is related to the finding of a quality defect.
© 2023 Medexpress. All Rights Reserved
